drugset / Trial / NCT03400735
Comparison of Cefdinir and Cefdinir/Clavulanic Acid Combination in Adults
RandomizedParallel-groupOpen-labelTreatment
Summary
It is planned to compare the efficacy and safety of cefdinir and cefdinir/clavulanic acide treatments in acute exacerbation of chronic bronchitis (AECB) and community-acquired pneumoniae (CAP) patients.
Timeline
- Start
- 2017-11-01
- Primary completion
- 2018-04-01
- Completion
- 2018-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | cefdinir | Other / unclassified | 300 mg | — |
| Subject | clavulanic acide | Unknown | 125 mg | — |